TOX促进原发性干燥综合征患者滤泡辅助性T细胞分化
研究比较原发性干燥综合征(pSS)患者与健康对照的初始CD4+ T细胞,发现pSS初始CD4+ T细胞活化、增殖及向滤泡辅助性T(Tfh)细胞分化潜能增高,TOX上调并促进Tfh极化。机制上IFN-α通过JAK-STAT1信号诱导TOX过表达,TOX调控BCL6表达,提示IFN-α-JAK-STAT1信号与TOX可能是pSS潜在治疗靶点。
要点
- pSS患者初始CD4+ T细胞活化、增殖及向Tfh细胞分化潜能高于健康对照。
- pSS初始CD4+ T细胞中TOX上调,促进T细胞活化与Tfh细胞极化。
- IFN-α经JAK-STAT1信号诱导TOX过表达,TOX结合BCL6位点调控其表达。
核心结论
- 作者认为pSS初始CD4+ T细胞中TOX上调并促进Tfh细胞分化,IFN-α-JAK-STAT1信号与TOX可能是pSS潜在治疗靶点。
研究设计与样本
- 研究检测pSS患者与健康对照初始CD4+ T细胞的活化、增殖和分化。
- 采用RNA测序鉴定差异表达基因,并通过过表达或沉默确定调控Tfh细胞的基因。
- 采用ATAC-seq联合ChIP-seq探索表观遗传机制,并用pSS相关细胞因子处理初始CD4+ T细胞探索上游信号通路。
主要发现
- pSS初始CD4+ T细胞具有更高的活化、增殖及向Tfh细胞分化潜能。
- TOX在pSS初始CD4+ T细胞中上调,并促进T细胞活化与Tfh细胞极化。
- 沉默pSS初始CD4+ T细胞中的TOX可下调BCL6表达并改变多个Tfh相关基因水平。
- ChIP-seq提示TOX结合于BCL6基因座,ATAC-seq在该处发现可及区域。
- IFN-α诱导TOX过表达,该效应可被JAK抑制剂和STAT1抑制剂减弱。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Whether naive CD4+ T cells are dysregulated and associated with the overactivation of CD4+ T cells in primary SS (pSS) remains unclear. We aimed to explore the role and underlying mechanism of naive CD4+ T cells in pSS. METHODS: We examined the activation, proliferation and differentiation of naive CD4+ T cells from pSS patients and healthy controls. Differentially expressed genes were identified using RNA sequencing, and were overexpressed or silenced to determine the gene regulating follicular helper T (Tfh) cells. Assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) with chromatin immunoprecipitation with high-throughput sequencing (ChIP-seq) was performed to explore the epigenetic mechanism. Naive CD4+ T cells were treated with pSS-related cytokines to explore the upstream signalling pathway. RESULTS: pSS naive CD4+ T cells had higher potentials of activation, proliferation and differentiation towards Tfh cells. Thymocyte selection-associated high mobility group box protein (TOX) was upregulated in pSS naive CD4+ T cells and promoted T cell activation and Tfh cell polarization. TOX silencing in pSS naive CD4+ T cells downregulated B cell lymphoma 6 (BCL6) expression and altered levels of multiple Tfh-associated genes. ChIP-seq analysis implied that TOX bound to the BCL6 locus, where there were accessible regions found by ATAC-seq. IFN-α induced TOX overexpression, which was attenuated by Janus kinase (JAK) and signal transducer and activator of transcription 1 (STAT1) inhibitors. CONCLUSION: Our data suggest that TOX in pSS naive CD4+ T cells is upregulated, which facilitates Tfh cell differentiation. Mechanistically, IFN-α induces TOX overexpression in naive CD4+ T cells through JAK-STAT1 signalling and TOX regulates BCL6 expression. Therefore, IFN-α-JAK-STAT1 signalling and TOX might be potential therapeutic targets in pSS.
引用
- Liu S, Yang Y, Zeng L, et al. TOX promotes follicular helper T cell differentiation in patients with primary Sjögren's syndrome. Rheumatology (Oxford). 2023. PMID: 35713502. doi:10.1093/rheumatology/keac304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。